Zoonotic Infections News

Thirty-five hospitals in the United States have been identified and designated as Ebola treatment centers, and more centers are expected to be named in the coming weeks, according to the CDC.

Phase 1 clinical trial results suggest a bivalent Ebola vaccine was safe and immunogenic in healthy adults, according to the NIH.

Analysis of the experimental drug cocktail ZMapp’s effect on Ebola virus may lead to more effective versions of the treatment, according to recent data.

WHO officials have confirmed an outbreak of plague in Madagascar, according to a press release.

Southern Afghanistan faces a potential reemergence of vector-borne and zoonotic diseases endemic to the region, possibly posing public health threats to military personnel stationed in the area, according to researchers from the United Kingdom.

The number of worldwide dracunculiasis cases has greatly declined during the past few years, according to recent findings in MMWR.

Case protocol from the first successful hemodialysis delivery to a patient with Ebola virus concerning patient safety and secondary transmission risks recently was presented at the American Society of Nephrology’s Kidney Week 2014 conference in Philadelphia.

A supercomputer is being used to simulate the effectiveness of new hypothetical Ebola virus treatments, according to a press release.

A new diagnostic test that can quickly and easily detect onchocerciasis will be distributed to areas in Africa where the disease still persists, according to a press release.

The Médecins Sans Frontières doctor treated for Ebola in New York is free of the virus and was discharged from Bellevue Hospital this morning, according to a press release.